Need help finding what you are looking for?
Contact Us
PUBLISHER: Transparency Market Research | PRODUCT CODE: 1420935
PUBLISHER: Transparency Market Research | PRODUCT CODE: 1420935
Liquid Biopsy Market [Application: Oncology, NIPT, Transplant Diagnostics; Circulating Biomarker: Circulating Tumor Cells (CTC), Free Nucleic Acid, Extracellular Vesicles] - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast, 2023-2031
PUBLISHED:
PAGES: 161 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Liquid Biopsy Market - Scope of Report
TMR's report on the global liquid biopsy market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global liquid biopsy market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global liquid biopsy market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the liquid biopsy market.
| Market Snapshot | |
|---|---|
| Market Value in 2023 | US$ 3.7 Bn |
| Market Value in 2031 | US$ 7.7 Bn |
| CAGR | 8.8% |
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global liquid biopsy market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global liquid biopsy market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global liquid biopsy market.
The report delves into the competitive landscape of the global liquid biopsy market. Key players operating in the global liquid biopsy market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global liquid biopsy market profiled in this report.
Key Questions Answered in Global liquid biopsy Market Report:
- What is the sales/revenue generated by liquid biopsy across all regions during the forecast period?
- What are the opportunities in the global liquid biopsy market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which segment is expected to generate the highest revenue globally in 2031?
- Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?
Liquid Biopsy Market - Research Objectives and Research Approach
The comprehensive report on the global liquid biopsy market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global liquid biopsy market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global liquid biopsy market.
Product Code: TMRGL22994
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions
3. Research Methodology
4. Executive Summary
5. Market Overview
- 5.1. Introduction
- 5.2. Market Dynamics
- 5.2.1. Drivers
- 5.2.2. Restraints
- 5.2.3. Opportunities
- 5.3. Key Trends Analysis
- 5.3.1. Demand Side Analysis
- 5.3.2. Supply Side Analysis
- 5.4. Key Market Indicators
- 5.5. Technological Overview Analysis
- 5.6. Porter's Five Forces Analysis
- 5.7. Industry SWOT Analysis
- 5.8. Value Chain Analysis
- 5.9. Regulatory Framework
- 5.10. Global Liquid Biopsy Market Analysis and Forecast, - 2017-2031
- 5.10.1. Market Value Projections (US$ Mn)
6. Global Liquid Biopsy Market Analysis and Forecast, by Application
- 6.1. Liquid Biopsy Market Size (US$ Mn) Forecast, by Application, 2017-2031
- 6.1.1. Oncology
- 6.1.2. NIPT
- 6.1.3. Transplant Diagnostics
- 6.1.4. Others
- 6.2. Incremental Opportunity, by Application
7. Global Liquid Biopsy Market Analysis and Forecast, by Circulating Biomarker
- 7.1. Liquid Biopsy Market Size (US$ Mn) Forecast, by Circulating Biomarker, 2017-2031
- 7.1.1. Circulating Tumor Cells (CTC)
- 7.1.2. Free Nucleic Acid
- 7.1.3. Exracellular Vesicles/Exosomes
- 7.2. Incremental Opportunity, by Circulating Biomarker
8. Global Liquid Biopsy Market Analysis and Forecast, by End-user
- 8.1. Liquid Biopsy Market Size (US$ Mn) Forecast, End-user, 2017-2031
- 8.1.1. Hospitals
- 8.1.2. Reference Laboratories
- 8.1.3. Academic and Research Institutes
- 8.1.4. Others
- 8.2. Incremental Opportunity, by End-user
9. Global Liquid Biopsy Market Analysis and Forecast, by Region
- 9.1. Liquid Biopsy Market Size (US$ Mn) Forecast, by Region, 2017-2031
- 9.1.1. North America
- 9.1.2. Europe
- 9.1.3. Asia Pacific
- 9.1.4. Middle East & Africa
- 9.1.5. South America
- 9.2. Incremental Opportunity, by Region
10. North America Liquid Biopsy Market Analysis and Forecast
- 10.1. Regional Snapshot
- 10.2. Brand Analysis
- 10.3. Price Trend Analysis
- 10.3.1. Weighted Average Price
- 10.4. Key Trends Analysis
- 10.4.1. Demand Side
- 10.4.2. Supplier Side
- 10.5. Liquid Biopsy Market Size (US$ Mn) Forecast, by Application, 2017-2031
- 10.5.1. Oncology
- 10.5.2. NIPT
- 10.5.3. Transplant Diagnostics
- 10.5.4. Others
- 10.6. Liquid Biopsy Market Size (US$ Mn) Forecast, by Circulating Biomarker, 2017-2031
- 10.6.1. Circulating Tumor Cells (CTC)
- 10.6.2. Free Nucleic Acid
- 10.6.3. Exracellular Vesicles/Exosomes
- 10.7. Liquid Biopsy Market Size (US$ Mn) Forecast, End-user - 2017-2031
- 10.7.1. Hospitals
- 10.7.2. Reference Laboratories
- 10.7.3. Academic and Research Institutes
- 10.7.4. Others
- 10.8. Liquid Biopsy Market Size (US$ Mn) Forecast, by Country - 2017-2031
- 10.8.1. U.S.
- 10.8.2. Canada
- 10.8.3. Rest of North America
- 10.9. Incremental Opportunity Analysis
11. Europe Liquid Biopsy Market Analysis and Forecast
- 11.1. Regional Snapshot
- 11.2. Brand Analysis
- 11.3. Price Trend Analysis
- 11.3.1. Weighted Average Price
- 11.4. Key Trends Analysis
- 11.4.1. Demand Side
- 11.4.2. Supplier Side
- 11.5. Liquid Biopsy Market Size (US$ Mn) Forecast, by Application, 2017-2031
- 11.5.1. Oncology
- 11.5.2. NIPT
- 11.5.3. Transplant Diagnostics
- 11.5.4. Others
- 11.6. Liquid Biopsy Market Size (US$ Mn) Forecast, by Circulating Biomarker, 2017-2031
- 11.6.1. Circulating Tumor Cells (CTC)
- 11.6.2. Free Nucleic Acid
- 11.6.3. Exracellular Vesicles/Exosomes
- 11.7. Liquid Biopsy Market Size (US$ Mn) Forecast, End-user, 2017-2031
- 11.7.1. Hospitals
- 11.7.2. Reference Laboratories
- 11.7.3. Academic and Research Institutes
- 11.7.4. Others
- 11.8. Liquid Biopsy Market Size (US$ Mn) Forecast, by Country, 2017-2031
- 11.8.1. U.K.
- 11.8.2. Germany
- 11.8.3. France
- 11.8.4. Rest of Europe
- 11.9. Incremental Opportunity Analysis
12. Asia Pacific Liquid Biopsy Market Analysis and Forecast
- 12.1. Regional Snapshot
- 12.2. Brand Analysis
- 12.3. Price Trend Analysis
- 12.3.1. Weighted Average Price
- 12.4. Key Trends Analysis
- 12.4.1. Demand Side
- 12.4.2. Supplier Side
- 12.5. Liquid Biopsy Market Size (US$ Mn) Forecast, by Application, 2017-2031
- 12.5.1. Oncology
- 12.5.2. NIPT
- 12.5.3. Transplant Diagnostics
- 12.5.4. Others
- 12.6. Liquid Biopsy Market Size (US$ Mn) Forecast, by Circulating Biomarker, 2017-2031
- 12.6.1. Circulating Tumor Cells (CTC)
- 12.6.2. Free Nucleic Acid
- 12.6.3. Exracellular Vesicles/Exosomes
- 12.7. Liquid Biopsy Market Size (US$ Mn) Forecast, End-user, 2017-2031
- 12.7.1. Hospitals
- 12.7.2. Reference Laboratories
- 12.7.3. Academic and Research Institutes
- 12.7.4. Others
- 12.8. Liquid Biopsy Market Size (US$ Mn) Forecast, by Country, 2017-2031
- 12.8.1. India
- 12.8.2. China
- 12.8.3. Japan
- 12.8.4. Rest of Asia Pacific
- 12.9. Incremental Opportunity Analysis
13. Middle East & South Africa Liquid Biopsy Market Analysis and Forecast
- 13.1. Regional Snapshot
- 13.2. Brand Analysis
- 13.3. Price Trend Analysis
- 13.3.1. Weighted Average Price
- 13.4. Key Trends Analysis
- 13.4.1. Demand Side
- 13.4.2. Supplier Side
- 13.5. Liquid Biopsy Market Size (US$ Mn) Forecast, by Application, 2017-2031
- 13.5.1. Oncology
- 13.5.2. NIPT
- 13.5.3. Transplant Diagnostics
- 13.5.4. Others
- 13.6. Liquid Biopsy Market Size (US$ Mn) Forecast, by Circulating Biomarker, 2017-2031
- 13.6.1. Circulating Tumor Cells (CTC)
- 13.6.2. Free Nucleic Acid
- 13.6.3. Exracellular Vesicles/Exosomes
- 13.7. Liquid Biopsy Market Size (US$ Mn) Forecast, End-user, 2017-2031
- 13.7.1. Hospitals
- 13.7.2. Reference Laboratories
- 13.7.3. Academic and Research Institutes
- 13.7.4. Others
- 13.8. Liquid Biopsy Market Size (US$ Mn) Forecast, by Country, 2017-2031
- 13.8.1. GCC
- 13.8.2. Rest of Middle East & Africa
- 13.9. Incremental Opportunity Analysis
14. South America Liquid Biopsy Market Analysis and Forecast
- 14.1. Regional Snapshot
- 14.2. Brand Analysis
- 14.3. Price Trend Analysis
- 14.3.1. Weighted Average Price
- 14.4. Key Trends Analysis
- 14.4.1. Demand Side
- 14.4.2. Supplier Side
- 14.5. Liquid Biopsy Market Size (US$ Mn) Forecast, by Application, 2017-2031
- 14.5.1. Oncology
- 14.5.2. NIPT
- 14.5.3. Transplant Diagnostics
- 14.5.4. Others
- 14.6. Liquid Biopsy Market Size (US$ Mn) Forecast, by Circulating Biomarker, 2017-2031
- 14.6.1. Circulating Tumor Cells (CTC)
- 14.6.2. Free Nucleic Acid
- 14.6.3. Exracellular Vesicles/Exosomes
- 14.7. Liquid Biopsy Market Size (US$ Mn) Forecast, End-user, 2017-2031
- 14.7.1. Hospitals
- 14.7.2. Reference Laboratories
- 14.7.3. Academic and Research Institutes
- 14.7.4. Others
- 14.8. Liquid Biopsy Market Size (US$ Mn) Forecast, by Country, 2017-2031
- 14.8.1. Brazil
- 14.8.2. Rest of South America
- 14.9. Incremental Opportunity Analysis
15. Competition Landscape
- 15.1. Market Player - Competition Dashboard
- 15.2. Market Share Analysis (%), by Company, (2022)
- 15.3. Company Profiles (Details - Company Overview, Sales Area/Geographical Presence, Revenue, Strategy & Business Overview)
- 15.3.1. Biocept, Inc.
- 15.3.1.1. Company Overview
- 15.3.1.2. Sales Area
- 15.3.1.3. Geographical Presence
- 15.3.1.4. Revenue
- 15.3.1.5. Strategy & Business Overview
- 15.3.2. MDxHealth
- 15.3.2.1. Company Overview
- 15.3.2.2. Sales Area
- 15.3.2.3. Geographical Presence
- 15.3.2.4. Revenue
- 15.3.2.5. Strategy & Business Overview
- 15.3.3. Myriad Genetics, Inc.
- 15.3.3.1. Company Overview
- 15.3.3.2. Sales Area
- 15.3.3.3. Geographical Presence
- 15.3.3.4. Revenue
- 15.3.3.5. Strategy & Business Overview
- 15.3.4. Bio-Rad Laboratories
- 15.3.4.1. Company Overview
- 15.3.4.2. Sales Area
- 15.3.4.3. Geographical Presence
- 15.3.4.4. Revenue
- 15.3.4.5. Strategy & Business Overview
- 15.3.5. QIAGEN
- 15.3.5.1. Company Overview
- 15.3.5.2. Sales Area
- 15.3.5.3. Geographical Presence
- 15.3.5.4. Revenue
- 15.3.5.5. Strategy & Business Overview
- 15.3.6. F. Hoffmann-La Roche Ltd.
- 15.3.6.1. Company Overview
- 15.3.6.2. Sales Area
- 15.3.6.3. Geographical Presence
- 15.3.6.4. Revenue
- 15.3.6.5. Strategy & Business Overview
- 15.3.7. Thermo Fisher Scientific, Inc.
- 15.3.7.1. Company Overview
- 15.3.7.2. Sales Area
- 15.3.7.3. Geographical Presence
- 15.3.7.4. Revenue
- 15.3.7.5. Strategy & Business Overview
- 15.3.8. Genomic Health, Inc.
- 15.3.8.1. Company Overview
- 15.3.8.2. Sales Area
- 15.3.8.3. Geographical Presence
- 15.3.8.4. Revenue
- 15.3.8.5. Strategy & Business Overview
- 15.3.9. Illumina, Inc.
- 15.3.9.1. Company Overview
- 15.3.9.2. Sales Area
- 15.3.9.3. Geographical Presence
- 15.3.9.4. Revenue
- 15.3.9.5. Strategy & Business Overview
- 15.3.10. Other Key Players
- 15.3.10.1. Company Overview
- 15.3.10.2. Sales Area
- 15.3.10.3. Geographical Presence
- 15.3.10.4. Revenue
- 15.3.10.5. Strategy & Business Overview
- 15.3.1. Biocept, Inc.
16. Go to Market Strategy
17. Identification of Potential Market Spaces
18. Prevailing Market Risks
19. Understanding Buying Process of Customers
20. Preferred Sales & Marketing Strategy
Product Code: TMRGL22994
List of Tables
- Table 1: Global Liquid Biopsy Market Value (US$ Mn), by Application, 2017-2031
- Table 2: Global Liquid Biopsy Market Value (US$ Mn), by Circulating Biomarker, 2017-2031
- Table 3: Global Liquid Biopsy Market Value (US$ Mn), by End-user, 2017-2031
- Table 4: Global Liquid Biopsy Market Value (US$ Mn), by Region, 2017-2031
- Table 5: North America Liquid Biopsy Market Value (US$ Mn), by Application, 2017-2031
- Table 6: North America Liquid Biopsy Market Value (US$ Mn), by Circulating Biomarker, 2017-2031
- Table 7: North America Liquid Biopsy Market Value (US$ Mn), by End-user, 2017-2031
- Table 8: North America Liquid Biopsy Market Value (US$ Mn), by Region, 2017-2031
- Table 9: Europe Liquid Biopsy Market Value (US$ Mn), by Application, 2017-2031
- Table 10: Europe Liquid Biopsy Market Value (US$ Mn), by Circulating Biomarker, 2017-2031
- Table 11: Europe Liquid Biopsy Market Value (US$ Mn), by End-user, 2017-2031
- Table 12: Europe Liquid Biopsy Market Value (US$ Mn), by Region, 2017-2031
- Table 13: Asia Pacific Liquid Biopsy Market Value (US$ Mn), by Application, 2017-2031
- Table 14: Asia Pacific Liquid Biopsy Market Value (US$ Mn), by Circulating Biomarker, 2017-2031
- Table 15: Asia Pacific Liquid Biopsy Market Value (US$ Mn), by End-user, 2017-2031
- Table 16: Asia Pacific Liquid Biopsy Market Value (US$ Mn), by Region, 2017-2031
- Table 17: Middle East & Africa Liquid Biopsy Market Value (US$ Mn), by Application, 2017-2031
- Table 18: Middle East & Africa Liquid Biopsy Market Value (US$ Mn), by Circulating Biomarker, 2017-2031
- Table 19: Middle East & Africa Liquid Biopsy Market Value (US$ Mn), by End-user, 2017-2031
- Table 20: Middle East & Africa Liquid Biopsy Market Value (US$ Mn), by Region, 2017-2031
- Table 21: South America Liquid Biopsy Market Value (US$ Mn), by Application, 2017-2031
- Table 22: South America Liquid Biopsy Market Value (US$ Mn), by Circulating Biomarker, 2017-2031
- Table 23: South America Liquid Biopsy Market Value (US$ Mn), by End-user, 2017-2031
- Table 24: South America Liquid Biopsy Market Value (US$ Mn), by Region, 2017-2031
List of Figures
- Figure 1: Global Liquid Biopsy Market Value (US$ Mn), by Application, 2017-2031
- Figure 2: Global Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Application, 2023-2031
- Figure 3: Global Liquid Biopsy Market Value (US$ Mn), by Circulating Biomarker, 2017-2031
- Figure 4: Global Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Circulating Biomarker, 2023-2031
- Figure 5: Global Liquid Biopsy Market Value (US$ Mn), by End-user, 2017-2031
- Figure 6: Global Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by End-user, 2023-2031
- Figure 7: Global Liquid Biopsy Market Value (US$ Mn), by Region, 2017-2031
- Figure 8: Global Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Region, 2023-2031
- Figure 9: North America Liquid Biopsy Market Value (US$ Mn), by Application, 2017-2031
- Figure 10: North America Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Application, 2023-2031
- Figure 11: North America Liquid Biopsy Market Value (US$ Mn), by Circulating Biomarker, 2017-2031
- Figure 12: North America Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Circulating Biomarker, 2023-2031
- Figure 13: North America Liquid Biopsy Market Value (US$ Mn), by End-user, 2017-2031
- Figure 14: North America Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by End-user, 2023-2031
- Figure 15: North America Liquid Biopsy Market Value (US$ Mn), by Region, 2017-2031
- Figure 16: North America Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Region, 2023-2031
- Figure 17: Europe Liquid Biopsy Market Value (US$ Mn), by Application, 2017-2031
- Figure 18: Europe Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Application, 2023-2031
- Figure 19: Europe Liquid Biopsy Market Value (US$ Mn), by Circulating Biomarker, 2017-2031
- Figure 20: Europe Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Circulating Biomarker, 2023-2031
- Figure 21: Europe Liquid Biopsy Market Value (US$ Mn), by End-user, 2017-2031
- Figure 22: Europe Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by End-user, 2023-2031
- Figure 23: Europe Liquid Biopsy Market Value (US$ Mn), by Region, 2017-2031
- Figure 24: Europe Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Region, 2023-2031
- Figure 25: Asia Pacific Liquid Biopsy Market Value (US$ Mn), by Application, 2017-2031
- Figure 26: Asia Pacific Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Application, 2023-2031
- Figure 27: Asia Pacific Liquid Biopsy Market Value (US$ Mn), by Circulating Biomarker, 2017-2031
- Figure 28: Asia Pacific Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Circulating Biomarker, 2023-2031
- Figure 29: Asia Pacific Liquid Biopsy Market Value (US$ Mn), by End-user, 2017-2031
- Figure 30: Asia Pacific Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by End-user, 2023-2031
- Figure 31: Asia Pacific Liquid Biopsy Market Value (US$ Mn), by Region, 2017-2031
- Figure 32: Asia Pacific Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Region, 2023-2031
- Figure 33: Middle East & Africa Liquid Biopsy Market Value (US$ Mn), by Application, 2017-2031
- Figure 34: Middle East & Africa Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Application, 2023-2031
- Figure 35: Middle East & Africa Liquid Biopsy Market Value (US$ Mn), by Circulating Biomarker, 2017-2031
- Figure 36: Middle East & Africa Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Circulating Biomarker, 2023-2031
- Figure 37: Middle East & Africa Liquid Biopsy Market Value (US$ Mn), by End-user, 2017-2031
- Figure 38: Middle East & Africa Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by End-user, 2023-2031
- Figure 39: Middle East & Africa Liquid Biopsy Market Value (US$ Mn), by Region, 2017-2031
- Figure 40: Middle East & Africa Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Region, 2023-2031
- Figure 41: South America Liquid Biopsy Market Value (US$ Mn), by Application, 2017-2031
- Figure 42: South America Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Application, 2023-2031
- Figure 43: South America Liquid Biopsy Market Value (US$ Mn), by Circulating Biomarker, 2017-2031
- Figure 44: South America Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Circulating Biomarker, 2023-2031
- Figure 45: South America Liquid Biopsy Market Value (US$ Mn), by End-user, 2017-2031
- Figure 46: South America Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by End-user, 2023-2031
- Figure 47: South America Liquid Biopsy Market Value (US$ Mn), by Region, 2017-2031
- Figure 48: South America Liquid Biopsy Market Incremental Opportunity (US$ Mn), Forecast, by Region, 2023-2031
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.